Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

US Patent 11369674 · Granted Jun 28, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenic multimeric respiratory syncytial virus polypeptides2025
Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and 2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and 2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and 2025
Trispecific binding proteins, methods, and uses thereof2025
Alphavirus replicon particle2025
Virus-like particles and methods of use2024
Virus-like particles and methods of use2024
Virus-like particles and methods of use2024
Alphavirus replicon vector and immunotherapy by administering same2024
N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and2024